News
Could Viking Therapeutics Stock Be a Millionaire Maker?
There aren't many hotter stocks on the market right now than Viking Therapeutics (NASDAQ: VKTX). Shares of the biopharmaceutical company have skyrocketed around 340% so far this year.
However, those
Why AT&T Stock Sagged on Monday
A major hacking incident disclosed over the weekend led to a minor sell-off in AT&T (NYSE: T) stock as the trading week kicked off on Monday. The telecom giant's shares dipped by 0.6% on the day
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
Investors looking for stocks that can make dramatic gains in a short time frame might want to turn their attention to the biopharmaceutical industry. Shares of Viking Therapeutics (NASDAQ: VKTX)
2 Stocks Down 30% and 27% to Buy and Hold
No pair of companies dominated the COVID-19 vaccine market quite like Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). Both saw their revenue and earnings skyrocket, along with their share prices, as
Better Recovery Story Buy: Pfizer vs Moderna
A few years ago, both Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were flying high: from an earnings and share performance perspective. They each sold a leading coronavirus vaccine -- and Pfizer
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
If you're an everyday investor looking for stocks that can deliver steadily rising dividend payouts over long periods, the healthcare sector is the right place to begin your search. People get sick
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
One of the biggest tailwinds in the pharmaceutical industry is weight loss treatments. Breakthroughs in semaglutide and tirzepatide have given rise to several glucagon-like peptide-1 (GLP-1)
1 Top Growth Stock to Buy and Hold Forever
Biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) has outperformed the S&P 500 in the past three, five, and 10 years. That's not a fluke: The drugmaker has been highly successful financially while
5 Top Stocks to Buy in April
2024 is off to a great start for many investors, with the S&P 500 climbing 10.2% in the first quarter, roughly the performance the index averages for an entire year. Since the end of 2022, the S&P
This Beleaguered Ultra-High-Yield Dividend Stock Might Soon Get Some Much-Needed Relief
Medical Properties Trust (NYSE: MPW) has fallen on hard times over the past few years. Shares of the hospital-focused real estate investment trust (REIT) have lost more than 80% of their value from
Will Artificial Intelligence (AI) Allow Nvidia to Crush Apple and Microsoft, and Become the Most Valuable "Magnificent Seven" Stock?
Nvidia (NASDAQ: NVDA) has emerged as the hottest player in the artificial intelligence (AI) space. Its cutting-edge graphics processing units (GPUs) are the most important hardware element of the
3 Unstoppable Stocks to Buy Hand Over Fist in April
The "it factor." Some stocks have it. Others don't. But when you find stocks with the "it factor," you'll want to load up on them.
Three Motley Fool contributors believe they've identified three
Why NovoCure Stock Soared 18.3% This Week
Shares of Novocure (NASDAQ: NVCR) jumped 18.3% this week, according to data from S&P Global Market Intelligence, after the company announced encouraging results from a phase 3 study of its Tumor
2 Tech Stocks That Are Still No-Brainer Bargains
The stock market is off to a great start this year, with the S&P 500 index up about 10% in just a few months. As stock prices rise, genuine bargains are becoming tougher to come by.
However, there
Why Summit Therapeutics Stock Crushed the Market This Week
One exceptional stock in the healthcare sector this trading week was Summit Therapeutics (NASDAQ: SMMT). Buoyed by encouraging news from the lab, the company got an additional boost on Monday with
Is It Too Late to Buy Viking Therapeutics Stock?
Viking Therapeutics (NASDAQ: VKTX) has emerged this year as a formidable contender in the increasingly popular anti-obesity market. While it doesn't have an approved drug fighting for market share
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
Relatively small biotechs can see their shares soar -- sometimes significantly -- following positive clinical or regulatory news.
That's what has happened this year to Viking Therapeutics (NASDAQ:
Why Viking Therapeutics Stock Was Rocketing Higher This Week
Investors are very eager to buy into biotechs and pharmaceuticals that are involved in developing weight-loss medications. This is why Viking Therapeutics (NASDAQ: VKTX), which has such a drug in
Why Novocure Stock Is Jumping Today
Shares of Novocure (NASDAQ: NVCR) were jumping 6.3% higher as of 11:15 a.m. ET on Thursday after rising as much as 9.2% earlier in the day. The nice gain came after the company announced results
EQS-News: Resolutions of the Annual General Meeting of Sartorius AG
EQS-News: Biotest AG increased sales by 32% in the financial year 2023
Better Cathie Wood Stock: Moderna vs. Intellia
Cathie Wood's latest stocks shopping spree included several healthcare innovators -- and she picked them up for a bargain. Wood isn't intimidated by shares that have wallowed in the doldrums because
5 Things You Need to Know If You Buy Viking Therapeutics Stock Today
What's the hottest biotech stock on the market right now? If we limit the list only to those with market caps of at least $500 million, it's Viking Therapeutics (NASDAQ: VKTX). So far in 2024
AT&T Has a Plan to Boost Business Revenue
Telecom giant AT&T (NYSE: T) has successfully kept its wireless business growing by attracting hundreds of thousands of new subscribers each quarter. The fiber internet business is also performing
2 Reasons to Buy Nvidia Stock Like There's No Tomorrow
Nvidia (NASDAQ: NVDA) has been on top of the world over the last year as it has cornered the market on artificial intelligence (AI) chips, with its stock up more than 247% since last March.
As